SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is experiencing significant volatility driven by index reconstitution selling and a specific pause in a Wyoming data center project, causing investors to weigh these temporary headwinds against the company's long-term role in AI power infrastructure. The community remains largely polarized, with many using the sharp price pullback as a high-conviction buying opportunity while others express caution regarding valuation sustainability and recent technical breakdowns.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community polarization as investors weigh the impact of its leveraged Bitcoin strategy against mounting concerns over shareholder dilution and dividend sustainability. The stock is a focal point for intense debate, with critics highlighting potential insolvency risks and liquidation pressures, while bullish participants view the current price compression as a generational buying opportunity tied to the long-term trajectory of Bitcoin.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing intense trading volume and volatility as investors actively debate the company's valuation, potential takeover rumors, and the upcoming annual meeting. Community sentiment is sharply divided between those calling for leadership changes due to prolonged price pressure and others highlighting the company's established commercial portfolio and late-stage pipeline as catalysts for a long-term recovery.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor Japan's recent move to explore rare earth opportunities in Greenland, sparking optimism that Tanbreez's heavy rare earth reserves will become a pivotal strategic asset for Western supply chain independence. Community sentiment remains polarized, with many longs citing the project's long-term geopolitical importance and recent drilling program as potential catalysts for a rerating, while others express frustration over the timing of management communications and the stock's recent price volatility.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing heightened trading volatility and community debate following the unexpected departure of a key executive and the announcement of new robotaxi partnerships and cost-cutting measures. Investors are closely monitoring the stock's heavy short interest and institutional activity while debating whether recent operational shifts signal a long-term turnaround or continued financial pressure.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors engage in a heated debate over whether the stock will graduate to the Russell 1000 index, with many bullish traders betting on forced institutional buying while skeptics warn of potential short-driven volatility. Community conversation is dominated by high-conviction longs anticipating a massive squeeze and long-term breakthroughs in oncology, countering persistent short-seller pressure.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing intense scrutiny as investors weigh the trade-offs of massive AI capital expenditures against near-term growth, with community discourse divided between those betting on long-term cloud infrastructure dominance and those frustrated by recent technical weakness. While sentiment remains volatile, recent data regarding robust Prime Day engagement and expansion in India is fueling ongoing debate about the company's ability to balance record-level investments with operational efficiency.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is rallying behind significant momentum fueled by positive subcutaneous clinical data and mounting community speculation surrounding potential M&A activity. Investors are actively discussing the stock's strong relative performance and potential for a breakout, while closely watching the heavy short interest as a catalyst for a possible squeeze.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending as the community reacts to a new distribution deal with NBCUniversal that restores key sports and entertainment channels ahead of the FIFA World Cup. While bulls view the partnership and market scale as a turnaround catalyst, skeptics remain focused on long-term stock performance and persistent volatility.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is facing intensified scrutiny as investors express concern over rising capital expenditure and the departure of key AI talent to rival labs. The community remains divided, with some traders debating potential valuation resets while others emphasize the company's long-term competitive moat and deep integration in search and cloud sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded by Eli Goldberger and Shalom Z. Hirschman on March 20, 1987 and is headquartered in Montvale, NJ.

EOM Pharmaceutical Holdings Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

IMUCImmunoCellular Therapeutics, Ltd.

Fundamentals

Latest IMUC News